204 related articles for article (PubMed ID: 18006823)
1. Pirh2 promotes ubiquitin-dependent degradation of the cyclin-dependent kinase inhibitor p27Kip1.
Hattori T; Isobe T; Abe K; Kikuchi H; Kitagawa K; Oda T; Uchida C; Kitagawa M
Cancer Res; 2007 Nov; 67(22):10789-95. PubMed ID: 18006823
[TBL] [Abstract][Full Text] [Related]
2. Cytoplasmic ubiquitin ligase KPC regulates proteolysis of p27(Kip1) at G1 phase.
Kamura T; Hara T; Matsumoto M; Ishida N; Okumura F; Hatakeyama S; Yoshida M; Nakayama K; Nakayama KI
Nat Cell Biol; 2004 Dec; 6(12):1229-35. PubMed ID: 15531880
[TBL] [Abstract][Full Text] [Related]
3. Degradation of p27(Kip1) at the G(0)-G(1) transition mediated by a Skp2-independent ubiquitination pathway.
Hara T; Kamura T; Nakayama K; Oshikawa K; Hatakeyama S; Nakayama K
J Biol Chem; 2001 Dec; 276(52):48937-43. PubMed ID: 11682478
[TBL] [Abstract][Full Text] [Related]
4. Cell adhesion induces p27Kip1-associated cell-cycle arrest through down-regulation of the SCFSkp2 ubiquitin ligase pathway in mantle-cell and other non-Hodgkin B-cell lymphomas.
Lwin T; Hazlehurst LA; Dessureault S; Lai R; Bai W; Sotomayor E; Moscinski LC; Dalton WS; Tao J
Blood; 2007 Sep; 110(5):1631-8. PubMed ID: 17502456
[TBL] [Abstract][Full Text] [Related]
5. Kip1 degradation via the ubiquitin-proteasome pathway.
Tam SW; Theodoras AM; Pagano M
Leukemia; 1997 Apr; 11 Suppl 3():363-6. PubMed ID: 9209391
[TBL] [Abstract][Full Text] [Related]
6. Involvement of two distinct ubiquitin E3 ligase systems for p27 degradation in corneal endothelial cells.
Lee JG; Kay EP
Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):189-96. PubMed ID: 18172092
[TBL] [Abstract][Full Text] [Related]
7. Evidence for cytosolic p27(Kip1) ubiquitylation and degradation during adipocyte hyperplasia.
Auld CA; Morrison RF
Obesity (Silver Spring); 2006 Dec; 14(12):2136-44. PubMed ID: 17189539
[TBL] [Abstract][Full Text] [Related]
8. Inducible expression of a degradation-resistant form of p27Kip1 causes growth arrest and apoptosis in breast cancer cells.
Zhang Q; Tian L; Mansouri A; Korapati AL; Johnson TJ; Claret FX
FEBS Lett; 2005 Jul; 579(18):3932-40. PubMed ID: 15996662
[TBL] [Abstract][Full Text] [Related]
9. USP19 deubiquitinating enzyme supports cell proliferation by stabilizing KPC1, a ubiquitin ligase for p27Kip1.
Lu Y; Adegoke OA; Nepveu A; Nakayama KI; Bedard N; Cheng D; Peng J; Wing SS
Mol Cell Biol; 2009 Jan; 29(2):547-58. PubMed ID: 19015242
[TBL] [Abstract][Full Text] [Related]
10. Skp2-mediated p27(Kip1) degradation during S/G2 phase progression of adipocyte hyperplasia.
Auld CA; Fernandes KM; Morrison RF
J Cell Physiol; 2007 Apr; 211(1):101-11. PubMed ID: 17096381
[TBL] [Abstract][Full Text] [Related]
11. A growth factor-dependent nuclear kinase phosphorylates p27(Kip1) and regulates cell cycle progression.
Boehm M; Yoshimoto T; Crook MF; Nallamshetty S; True A; Nabel GJ; Nabel EG
EMBO J; 2002 Jul; 21(13):3390-401. PubMed ID: 12093740
[TBL] [Abstract][Full Text] [Related]
12. Helicobacter pylori increases proteasome-mediated degradation of p27(kip1) in gastric epithelial cells.
Eguchi H; Herschenhous N; Kuzushita N; Moss SF
Cancer Res; 2003 Aug; 63(15):4739-46. PubMed ID: 12907657
[TBL] [Abstract][Full Text] [Related]
13. Regulation of p27 degradation and S-phase progression by Ro52 RING finger protein.
Sabile A; Meyer AM; Wirbelauer C; Hess D; Kogel U; Scheffner M; Krek W
Mol Cell Biol; 2006 Aug; 26(16):5994-6004. PubMed ID: 16880511
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of F-Box protein p45(SKP2) expression and stabilization of cyclin-dependent kinase inhibitor p27(KIP1) in vitamin D analog-treated cancer cells.
Lin R; Wang TT; Miller WH; White JH
Endocrinology; 2003 Mar; 144(3):749-53. PubMed ID: 12586749
[TBL] [Abstract][Full Text] [Related]
15. Targeted disruption of Skp2 results in accumulation of cyclin E and p27(Kip1), polyploidy and centrosome overduplication.
Nakayama K; Nagahama H; Minamishima YA; Matsumoto M; Nakamichi I; Kitagawa K; Shirane M; Tsunematsu R; Tsukiyama T; Ishida N; Kitagawa M; Nakayama K; Hatakeyama S
EMBO J; 2000 May; 19(9):2069-81. PubMed ID: 10790373
[TBL] [Abstract][Full Text] [Related]
16. Skp2 regulates G2/M progression in a p53-dependent manner.
Hu R; Aplin AE
Mol Biol Cell; 2008 Nov; 19(11):4602-10. PubMed ID: 18716061
[TBL] [Abstract][Full Text] [Related]
17. BCR-ABL induces the expression of Skp2 through the PI3K pathway to promote p27Kip1 degradation and proliferation of chronic myelogenous leukemia cells.
Andreu EJ; Lledó E; Poch E; Ivorra C; Albero MP; Martínez-Climent JA; Montiel-Duarte C; Rifón J; Pérez-Calvo J; Arbona C; Prósper F; Pérez-Roger I
Cancer Res; 2005 Apr; 65(8):3264-72. PubMed ID: 15833859
[TBL] [Abstract][Full Text] [Related]
18. p27Kip1 repression of ErbB2-induced mammary tumor growth in transgenic mice involves Skp2 and Wnt/beta-catenin signaling.
Hulit J; Lee RJ; Li Z; Wang C; Katiyar S; Yang J; Quong AA; Wu K; Albanese C; Russell R; Di Vizio D; Koff A; Thummala S; Zhang H; Harrell J; Sun H; Muller WJ; Inghirami G; Lisanti MP; Pestell RG
Cancer Res; 2006 Sep; 66(17):8529-41. PubMed ID: 16951165
[TBL] [Abstract][Full Text] [Related]
19. Differential response between the p53 ubiquitin-protein ligases Pirh2 and MdM2 following DNA damage in human cancer cells.
Duan W; Gao L; Wu X; Zhang Y; Otterson GA; Villalona-Calero MA
Exp Cell Res; 2006 Oct; 312(17):3370-8. PubMed ID: 16934800
[TBL] [Abstract][Full Text] [Related]
20. Role of the UBL-UBA protein KPC2 in degradation of p27 at G1 phase of the cell cycle.
Hara T; Kamura T; Kotoshiba S; Takahashi H; Fujiwara K; Onoyama I; Shirakawa M; Mizushima N; Nakayama KI
Mol Cell Biol; 2005 Nov; 25(21):9292-303. PubMed ID: 16227581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
